Browse the full record of transactions filed by ALBINI EDWARD C, Chief Financial Officer. Insider active across 1 companies, notably Sutro Biopharma, INC.. In total, 5 filings have been logged. The latest transaction was filed on 29 January 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
5 of 5 declarations
Edward C. Albini is the CFO and Secretary of SUTRO BIOPHARMA, INC. In this role, he oversees the financial and administrative operations of the company. With a strong background in finance, he is responsible for financial planning, financial reporting, and regulatory compliance. His expertise is essential in ensuring the financial health of SUTRO BIOPHARMA and supporting its mission of innovation in the biopharmaceutical field.